12 T2WIにて周辺部low intensityを伴うependymomaの2症例(北日本脳神経外科連合会第28回学術集会)

departmental bulletin pape

arundinacea

Phalaris arundinacea Linnaeusreed canary grass;reedgrassalpiste roseau;phalaris roseau;roseau;phalaride vivace;baldingère;baldingère faux-roseau;alpiste faux-roseauarundinaceaNorth Maple Street, Hadleymeado

近世における漁業経営と地域社会

論文(Article)departmental bulletin pape

植民地期カンボジアにおける大臣の称号・職名 : 大臣会議の構成員を規定する王令を中心に

2016-06-01This paper tries to organize honorary titles and job titles of ministers in French Colonial Cambodia according to provisions of a series of the Royal Ordinances (les Ordonnances Royales) that prescribed the composition of the Council of Ministers (le Conseil des Ministres). The Council of Ministers was the most important organization in colonial politics. It exercised the executive power, served as a legislative body by drafting Royal Ordinances and proposing the King to promulgate them, and was also the supreme court before the court of cassation (le Cour de Cassation) was established in 1911. The Council, which consisted of five ministers and was presided over by the French Resident Superior (le Resident superieur), was re-organized and provided legal basis by the Royal Ordinance No. 54 dated July 11, 1897. The Ordinance referred to the ministers not by their job titles such as the Minister of Interior and Religion, but by their honorary titles like “Akha Moha Sena”, except for the Minister of Justice mentioned in article 6. It was the Royal Ordinance No. 33 dated July 3, 1905 that provided for membership of the Council by use of job titles at the first time. The Royal Ordinances No. 28 dated February 20, 1912 and No. 112 dated December 31, 1926 revised the former ordinance, and job titles were changed in association with them. Through this study, we can recognize the connection between honorary titles and job titles of ministers and the variation of job titles from 1897 to 1940.departmental bulletin pape

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas-0

<p><b>Copyright information:</b></p><p>Taken from "Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas"</p><p>http://www.translational-medicine.com/content/5/1/67</p><p>Journal of Translational Medicine 2007;5():67-67.</p><p>Published online 19 Dec 2007</p><p>PMCID:PMC2254376.</p><p></p>that were not stimulated with the type-1 cytokine-mixture (standard DCs). This was done with 24 hr stimulation of DCs (20 × 10per well, duplicates) with CD40L-transfected J558 cells (50 × 10per well). Supernatant was harvested and the production of IL-12 p70 was assayed by specific ELISA. Values indicate averages of duplicate samples. Bars indicate standard errors

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas-2

<p><b>Copyright information:</b></p><p>Taken from "Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas"</p><p>http://www.translational-medicine.com/content/5/1/67</p><p>Journal of Translational Medicine 2007;5():67-67.</p><p>Published online 19 Dec 2007</p><p>PMCID:PMC2254376.</p><p></p> by a neuroradiologist

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas-1

<p><b>Copyright information:</b></p><p>Taken from "Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas"</p><p>http://www.translational-medicine.com/content/5/1/67</p><p>Journal of Translational Medicine 2007;5():67-67.</p><p>Published online 19 Dec 2007</p><p>PMCID:PMC2254376.</p><p></p>aved as frozen cells until all these cells were thawed at the same time, cultured in the presence of 20 IU/ml hIL-2 and autologous glioma cells for 5 days, and evaluated for the frequency of IFN-γ-producing cells in response to T2 cells loaded with the HLA-A2-binding EphA2peptide using ELISPOT assay. Each well contained 5 × 10CD8cells and each group was evaluated in triplicate. Specific IFN-γ spots were calculated by subtracting the average of control spots (triplicate variation within a group was less than 10% in non-peptide-loaded T2 cell groups) from the total numbers of spots in peptide-loaded groups. Values indicate averages of triplicate samples for each time point, and bars indicate standard deviations. The number of spots in each post-vaccine time point was at least three times the standard-deviation of the pre-vaccine value